High-dose rifampicin in tuberculosis: experiences from a Dutch tuberculosis centre

C. Seijger (Nijmegen, Netherlands), W. Hoefsloot (Nijmegen, Netherlands), I. Bergsma (Nijmegen, Netherlands), J. Van Ingen (Nijmegen, Netherlands), S. Kuijpers (Nijmegen, Netherlands), L. Te Brake (Nijmegen, Netherlands), R. Van Crevel (Nijmegen, Netherlands), R. Aarnoutse (Nijmegen, Netherlands), M. Boeree (Nijmegen, Netherlands), C. Magis-Escurra (Nijmegen, Netherlands)

Source: International Congress 2019 – Drug-resistant tuberculosis
Session: Drug-resistant tuberculosis
Session type: Oral Presentation
Number: 2132
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Seijger (Nijmegen, Netherlands), W. Hoefsloot (Nijmegen, Netherlands), I. Bergsma (Nijmegen, Netherlands), J. Van Ingen (Nijmegen, Netherlands), S. Kuijpers (Nijmegen, Netherlands), L. Te Brake (Nijmegen, Netherlands), R. Van Crevel (Nijmegen, Netherlands), R. Aarnoutse (Nijmegen, Netherlands), M. Boeree (Nijmegen, Netherlands), C. Magis-Escurra (Nijmegen, Netherlands). High-dose rifampicin in tuberculosis: experiences from a Dutch tuberculosis centre. 2132

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: